Successful Treatment of Recurrent Pulmonary Mucormycosis in a Renal Transplant Patient: A Case Report and Literature Review
Autor: | Monica Lobo, Alison Smith, Anil Paramesh, Morgan S. Martin |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
medicine.medical_specialty medicine.medical_treatment 030106 microbiology lcsh:Surgery Case Report Disease 030230 surgery End stage renal disease 03 medical and health sciences 0302 clinical medicine Management of Technology and Innovation Back pain Medicine Renal agenesis Kidney transplantation Debridement business.industry lcsh:RD1-811 Isavuconazonium medicine.disease Empyema Surgery medicine.symptom business medicine.drug |
Zdroj: | Case Reports in Transplantation, Vol 2017 (2017) Case Reports in Transplantation |
ISSN: | 2090-6951 2090-6943 |
Popis: | Background. We describe the unusual case of a recently transplanted cadaveric renal transplant recipient who presented with recurrent pulmonary mucormycosis. Case Report. An 18-year-old man with end stage renal disease secondary to congenital renal agenesis status after cadaveric kidney transplant 4 months before presented with acute onset of fever, hemoptysis, and back pain. The patient underwent an emergent left lower lobectomy due to the critical nature of his illness. He was also treated with amphotericin with resolution of his symptoms. One week later, he had evidence of recurrent disease on imaging with a surgical site infection. He underwent reexploration with evacuation of an empyema and debridement of a surgical site infection. He was continued on IV antifungal therapy with isavuconazonium and amphotericin. Radiographic clearance of disease with three months of treatment was apparent with no evidence of recurrence at seven-month follow-up. Discussion. Opportunistic infections in solid organ transplant patients represent a significant source of morbidity and mortality. Most patients are treated with prophylactic anti-infective agents. However, rare infections such as pulmonary mucormycosis remain a risk. The transplant physician must be aware of these uncommon infections and their treatment strategies, including the management of uncommon recurrent disease. |
Databáze: | OpenAIRE |
Externí odkaz: |